In Utero Exposure to COVID-19 Not Tied to Later Neurodevelopmental Issues
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- Exposure to maternal COVID-19 is not associated with abnormal neurodevelopmental screening results through 24 months postpartum, according to a study published online Oct. 16 in JAMA Network Open.
Eleni G. Jaswa, M.D., from University of California, San Francisco, and colleagues assessed whether in utero exposure to maternal COVID-19 is associated with abnormal neurodevelopmental scores among children ages 12, 18, and 24 months. The analysis included 2,003 pregnant individuals and neurodevelopmental outcomes from 1,757 children at 12 months, 1,522 at 18 months, and 1,523 at 24 months.
The researchers found that the prevalence of abnormal screens for exposed versus unexposed offspring at age 12 months was 32.3 versus 29.4 percent; 22.4 versus 20.5 percent at age 18 months; and 19.2 versus 16.8 percent at 24 months. At all three time points, there was no difference in the risk for abnormal neurodevelopmental screens (12 months: adjusted risk ratio [aRR], 1.07; 95 percent confidence interval [CI], 0.85 to 1.34; 18 months: aRR, 1.15; 95 percent CI, 0.84 to 1.57; 24 months: aRR, 1.01; 95 percent CI, 0.69 to 1.48). No differential risk was seen based on trimester of infection, presence versus absence of fever, or breakthrough infection following vaccination versus primary infection.
“These findings suggest that individuals infected with SARS-CoV-2 during pregnancy can be reassured that there is no association with abnormal neurodevelopmental scores in children through age 24 months,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-18 12:00
Read more
- Ketamine ODs Like the One That Killed Matthew Perry Are Rare But Increasing
- July 2019 to June 2023 Saw Increase in OD Deaths With Ketamine Detected
- Young Adults Born Preterm Face Economic and Educational Challenges
- Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
- Decline Expected in HIV Care Providers in Next Five Years
- Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions